CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,054 enrolled
Drug / intervention
Personalized Information +2 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03509467
NCT03509467N/ACompleted
CompareCT.gov

Using MC1R Genotype to Impact Melanoma Risk Behavior

H. Lee Moffitt Cancer Center and Research Institute·interventional·Posted Apr 26, 2018·Updated Dec 19, 2025

In Brief

A clinical study evaluating Personalized Information, Standard Information, and 1 other intervention for Melanoma (Skin) and 5 related conditions. Completed, enrolled 2,054 participants across 2 sites in 2 countries.

Detailed Summary

The purpose of this study is to examine how different messages about risk of melanoma can impact the way people protect themselves against developing these diseases.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMelanoma (Skin), Squamous Cell Carcinoma, Squamous Cell Cancer, Skin Cancer, Basal Cell Carcinoma, Basal Cell Cancer
CountriesPuerto Rico, United States
CollaboratorsPonce Health Sciences University, University of South Florida, American Cancer Society, Inc.

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 26, 2018
Enrollment StartAug 3, 2015
Primary CompletionFeb 19, 2021
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 8.2 years ago

Interventions

Personalized Informationbehavioral

Personalized information about ways that participants can protect themselves and their child from developing melanoma.

Standard Informationbehavioral

Standard information about ways that participants can protect themselves and their child from developing melanoma.

DNA Extraction Determination of MC1R Genotypesother

After signing informed consent, a biologic sample (saliva) will be collected for the purpose of DNA extraction determination of MC1R genotypes. All participants who carry high risk MC1R genotypes and a proportion of those who carry low risk or no MC1R variants will be randomized to the control or intervention arm.